Analyst Ratings for Inozyme Pharma Inc. (INZY)

INZY Rating Summary

  |   Expand Research on INZY
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3 / 10   Percentile Rank: 26%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/19/2025 Piper Sandler Allison M. Bratzel Downgrade Neutral
(Overweight)		 4.00
(N/A)		 1.42
(4.00)		 181.69% Details
5/19/2025 TD Cowen Marc Frahm Downgrade Hold
(Buy)		 4.00
(N/A)		 1.42
(4.00)		 181.69% Details